PON1 and Alzheimer disease: PON1 is one of the main contributors to the atheroprotective properties of HDLs, and decrease in its activity is associated to higher risk of developing CVD, as well as other diseases where oxidative stress (OxS) or inflammation play a pathogenic role, including AD [26,27,28].